Cytosorbents Corp
A critical care company specializing in blood purification technology for life-threats.
CTSO | US
Overview
Corporate Details
- ISIN(s):
- US23283X2062
- LEI:
- Country:
- United States of America
- Address:
- 305 COLLEGE ROAD EAST, 8540 PRINCETON
- Website:
- https://cytosorbents.com/
- Sector:
- Manufacturing
Description
Cytosorbents Corporation is a critical care company specializing in blood purification technology to treat life-threatening conditions. Its proprietary platform is based on biocompatible, highly porous polymer beads that use hemoadsorption to remove harmful substances, such as inflammatory mediators and certain drugs, from blood. The company's flagship product, CytoSorb, is an extracorporeal blood purification therapy used in intensive care units and during cardiac surgery to help restore physiological balance. The technology is also applied in other products for ex vivo organ perfusion (ECOS-300CY) and veterinary critical care (VetResQ).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cytosorbents Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cytosorbents Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cytosorbents Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
